Korean Drug (Korea) Market Value

014570 Stock  KRW 4,610  5.00  0.11%   
Korean Drug's market value is the price at which a share of Korean Drug trades on a public exchange. It measures the collective expectations of Korean Drug Co investors about its performance. Korean Drug is trading at 4610.00 as of the 29th of November 2024, a 0.11 percent increase since the beginning of the trading day. The stock's open price was 4605.0.
With this module, you can estimate the performance of a buy and hold strategy of Korean Drug Co and determine expected loss or profit from investing in Korean Drug over a given investment horizon. Check out Korean Drug Correlation, Korean Drug Volatility and Korean Drug Alpha and Beta module to complement your research on Korean Drug.
Symbol

Please note, there is a significant difference between Korean Drug's value and its price as these two are different measures arrived at by different means. Investors typically determine if Korean Drug is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Korean Drug's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Korean Drug 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Korean Drug's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Korean Drug.
0.00
10/30/2024
No Change 0.00  0.0 
In 30 days
11/29/2024
0.00
If you would invest  0.00  in Korean Drug on October 30, 2024 and sell it all today you would earn a total of 0.00 from holding Korean Drug Co or generate 0.0% return on investment in Korean Drug over 30 days. Korean Drug is related to or competes with SM Entertainment, Korea Computer, Alton Sports, CG Hi, Shinsegae Information, Tamul Multimedia, and Barunson Entertainment. Korean Drug Co., Ltd. researches, develops, manufactures, and markets medicines for treating human illness in South Kore... More

Korean Drug Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Korean Drug's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Korean Drug Co upside and downside potential and time the market with a certain degree of confidence.

Korean Drug Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Korean Drug's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Korean Drug's standard deviation. In reality, there are many statistical measures that can use Korean Drug historical prices to predict the future Korean Drug's volatility.
Hype
Prediction
LowEstimatedHigh
4,6094,6104,611
Details
Intrinsic
Valuation
LowRealHigh
4,0034,0055,071
Details
Naive
Forecast
LowNextHigh
4,5504,5514,552
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
4,3754,7435,111
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Korean Drug. Your research has to be compared to or analyzed against Korean Drug's peers to derive any actionable benefits. When done correctly, Korean Drug's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Korean Drug.

Korean Drug Backtested Returns

Korean Drug has Sharpe Ratio of -0.17, which conveys that the firm had a -0.17% return per unit of risk over the last 3 months. Korean Drug exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Korean Drug's Standard Deviation of 1.45, mean deviation of 1.02, and Risk Adjusted Performance of (0.15) to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.1, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Korean Drug's returns are expected to increase less than the market. However, during the bear market, the loss of holding Korean Drug is expected to be smaller as well. At this point, Korean Drug has a negative expected return of -0.23%. Please make sure to verify Korean Drug's jensen alpha, treynor ratio, value at risk, as well as the relationship between the total risk alpha and maximum drawdown , to decide if Korean Drug performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  -0.64  

Very good reverse predictability

Korean Drug Co has very good reverse predictability. Overlapping area represents the amount of predictability between Korean Drug time series from 30th of October 2024 to 14th of November 2024 and 14th of November 2024 to 29th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Korean Drug price movement. The serial correlation of -0.64 indicates that roughly 64.0% of current Korean Drug price fluctuation can be explain by its past prices.
Correlation Coefficient-0.64
Spearman Rank Test0.0
Residual Average0.0
Price Variance2183.06

Korean Drug lagged returns against current returns

Autocorrelation, which is Korean Drug stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Korean Drug's stock expected returns. We can calculate the autocorrelation of Korean Drug returns to help us make a trade decision. For example, suppose you find that Korean Drug has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Korean Drug regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Korean Drug stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Korean Drug stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Korean Drug stock over time.
   Current vs Lagged Prices   
       Timeline  

Korean Drug Lagged Returns

When evaluating Korean Drug's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Korean Drug stock have on its future price. Korean Drug autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Korean Drug autocorrelation shows the relationship between Korean Drug stock current value and its past values and can show if there is a momentum factor associated with investing in Korean Drug Co.
   Regressed Prices   
       Timeline  

Pair Trading with Korean Drug

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Korean Drug position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Korean Drug will appreciate offsetting losses from the drop in the long position's value.

Moving together with Korean Stock

  0.89102940 Kolon Life SciencePairCorr
  0.84074430 Aminologics CoLtdPairCorr

Moving against Korean Stock

  0.4216080 JETEMAPairCorr
The ability to find closely correlated positions to Korean Drug could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Korean Drug when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Korean Drug - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Korean Drug Co to buy it.
The correlation of Korean Drug is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Korean Drug moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Korean Drug moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Korean Drug can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Korean Stock

Korean Drug financial ratios help investors to determine whether Korean Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Korean with respect to the benefits of owning Korean Drug security.